...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >The role of Arg(78) in the metabotropic glutamate receptor mGlu(1) for agonist binding and selectivity.
【24h】

The role of Arg(78) in the metabotropic glutamate receptor mGlu(1) for agonist binding and selectivity.

机译:Arg(78)在促代谢型谷氨酸受体mGlu(1)中对激动剂结合和选择性的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The metabotropic glutamate receptors belong to family C of the G-protein coupled receptor superfamily. These receptors all possess large extracellular amino terminal domains, where agonist binding takes place. We have previously constructed a molecular model of the amino terminal domain of the mGlu(1) receptor based on a weak amino acid sequence similarity with a family of bacterial periplasmic binding proteins (PBPs). The residues Ser(165) and Thr(188) were demonstrated to be involved in agonist binding to the receptor. Here, we report that mutation of Arg(78) in the mGlu(1b) receptor to leucine or glutamate completely knocks out [3H]quisqualic acid binding to the receptor. The constructed mutants, R78L and R78E, have also been characterized in a inositol phosphate assay. Here, the potency of (S)-glutamic acid and (S)-quisqualic acid was reduced 1000- and 100-fold, respectively, on R78L compared to the wild type (WT) receptor. (S)-Quisqualic acid was as potent on mutant R78E as it was on R78L, whereas (S)-glutamic acid was unable to activate R78E significantly at concentrations up to 10 mM. In conclusion, Arg(78) appears to be essential for agonist binding to the mGlu(1) receptor, most likely, through the formation of an ionic bond between its positively charged side chain and the distal acid group of the agonists. Furthermore, the different impact of the two mutations on (S)-glutamic acid and (S)-quisqualic acid potencies strongly indicates that while Arg(78) appears to be a common site of interaction for the agonists, the Group I subtype selectivity of (S)-quisqualic acid is probably determined by other residues in the amino terminal domain.
机译:代谢型谷氨酸受体属于G蛋白偶联受体超家族的C族。这些受体都具有大的细胞外氨基末端结构域,在此发生激动剂结合。我们先前已经建立了基于与细菌周质结合蛋白(PBPs)家族的弱氨基酸序列相似性的mGlu(1)受体的氨基末端结构域的分子模型。已证明残基Ser(165)和Thr(188)参与激动剂与受体的结合。在这里,我们报告说,mGlu(1b)受体中的Arg(78)突变为亮氨酸或谷氨酸,完全敲除了与该受体结合的[3H]喹尿酸。所构建的突变体R78L和R78E也已通过磷酸肌醇测定进行了表征。在这里,与野生型(WT)受体相比,R78L上的(S)-谷氨酸和(S)-半角鲨酸的效力分别降低了1000倍和100倍。 (S)-喹尿酸在突变体R78E上的作用与在R78L上一样强,而(S)-谷氨酸在浓度高达10 mM时不能显着激活R78E。总之,Arg(78)似乎是激动剂与mGlu(1)受体结合所必需的,很可能是通过在其带正电荷的侧链与激动剂的远端酸基团之间形成离子键来实现的。此外,这两个突变对(S)-谷氨酸和(S)-半角鲨酸效力的不同影响强烈表明,虽然Arg(78)似乎是激动剂相互作用的共同位点,但I型亚型的选择性(S)-半胱氨酸可能是由氨基末端结构域中的其他残基决定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号